ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 1844

$1.74M Total Retail Price of All Prescriptions

Rank: 6 out of 1844

779 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 779 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 779 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 17,670 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,036 637 S3 1 2
FUROSEMIDE 753 586 2 7
OMEPRAZOLE 729 488 3 5
AMLODIPINE BESYLATE 604 492 4 6
LISINOPRIL 573 385 5 4
LEVOTHYROXINE SODIUM 570 435 6 1
SIMVASTATIN 522 419 7 3
CITALOPRAM HBR 469 340 8 19
POTASSIUM CHLORIDE 372 290 9 16
METOPROLOL SUCCINATE 368 305 10 14
ZOLPIDEM TARTRATE 343 171 11 23
HYDROCHLOROTHIAZIDE 329 236 12 9
WARFARIN SODIUM 325 289 13 13
METFORMIN HCL ER 282 174 14 46
PANTOPRAZOLE SODIUM 278 208 15 32
NAMENDA 277 258 16 33
DONEPEZIL HCL 271 250 17 26
GABAPENTIN 269 150 18 15
METOPROLOL TARTRATE 264 205 19 11
TRAMADOL HCL 253 169 20 18
CARVEDILOL 242 177 21 22
ATENOLOL 234 142 22 17
TAMSULOSIN HCL 230 180 23 27
ATORVASTATIN CALCIUM 223 145 24 12
AZITHROMYCIN 201 146 25 37
CIPROFLOXACIN HCL 179 134 26 62
PROAIR HFA 177 76 27 45
MELOXICAM 170 127 28 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 168 105 29 20
JANUVIA 168 117 29 77
ISOSORBIDE MONONITRATE ER 167 127 31 59
LOSARTAN POTASSIUM 166 166 32 24
LYRICA 165 67 33 92
SERTRALINE HCL 164 89 34 21
TRAZODONE HCL 162 103 35 43
NOVOLOG 156 82 36 84
BYSTOLIC 156 139 36 106
METFORMIN HCL 151 98 38 8
CYMBALTA 149 92 39 36
ESCITALOPRAM OXALATE 149 89 39 52
PRAVASTATIN SODIUM 147 96 41 10
GLIMEPIRIDE 147 127 41 35
FLUOXETINE HCL 144 66 43 41
ALLOPURINOL 141 138 44 29
SPIRIVA 140 72 45 57
DOXYCYCLINE HYCLATE 134 78 46 90
LANTUS 131 64 47 42
CLONIDINE HCL 126 74 48 64
HYDROXYZINE HCL 126 62 R 48 164
PREDNISONE 124 111 50 40
FLUTICASONE PROPIONATE 124 77 50 50
MUPIROCIN 123 78 52 189
NAPROXEN 122 90 53 87
ADVAIR DISKUS 122 84 53 51
FINASTERIDE 121 93 55 137
POLYETHYLENE GLYCOL 3350 121 91 55 39
OXYBUTYNIN CHLORIDE ER 118 99 57 126
LEVOFLOXACIN 118 85 57 78
BACLOFEN 115 15 59 119
OXYBUTYNIN CHLORIDE 114 66 60 103
FAMOTIDINE 114 94 60 63
CLOPIDOGREL 112 99 62 34
METOCLOPRAMIDE HCL 112 60 62 148
DIOVAN 110 91 64 58
MIRTAZAPINE 110 84 64 49
KLOR-CON M20 109 83 66 54
XARELTO 104 87 67 332
NEXIUM 103 62 68 31
DIGOXIN 103 88 68 67
FENTANYL 102 60 S2 70 66
ROPINIROLE HCL 101 58 71 76
CARBIDOPA-LEVODOPA 100 91 72 86
PAROXETINE HCL 100 59 72 68
LEVETIRACETAM 99 43 74 105
VOLTAREN 98 78 75 246
SPIRONOLACTONE 98 72 75 60
VESICARE 95 83 77 182
CELEBREX 94 73 78 91
AVODART 92 65 79 219
CRESTOR 92 51 79 30
SYNTHROID 89 57 81 55
WELCHOL 87 56 82 233
LANTUS SOLOSTAR 87 65 82 97
AMITRIPTYLINE HCL 87 26 R 82 72
EXELON 85 85 85 112
PROMETHAZINE HCL 85 46 R 85 88
ENALAPRIL MALEATE 84 69 87 69
NYSTATIN 83 60 88 85
VERAPAMIL ER 80 63 89 98
CYCLOBENZAPRINE HCL 80 23 R 89 53
RISPERIDONE 78 69 91 65
AMOX TR-POTASSIUM CLAVULANATE 77 48 92 139
METHADONE HCL 77 0 S2 92 133
VENLAFAXINE HCL ER 76 62 94 93
KLOR-CON 10 73 56 95 123
AMLODIPINE BESYLATE-BENAZEPRIL 72 56 96 80
ACTOS 71 42 97 130
RANITIDINE HCL 71 47 97 38
CILOSTAZOL 69 40 99 235
INSULIN SYRINGE 69 21 99 111
QUINAPRIL HCL 69 51 99 152
MORPHINE SULFATE ER 69 0 S2 99 107
BUSPIRONE HCL 68 43 103 127
PEN NEEDLE 68 42 103 135
LEXAPRO 66 52 105 179
PLAVIX 66 56 105 61
HUMALOG 65 38 107 114
PHENYTOIN SODIUM EXTENDED 65 15 107 147
DICYCLOMINE HCL 64 31 109 197
CEFTRIAXONE 64 53 109 213
SYMBICORT 64 33 109 134
ESTRADIOL 63 42 R 112 181
ONGLYZA 63 35 112 206
OXYCODONE-ACETAMINOPHEN 62 41 S2 114 94
SINGULAIR 61 19 115 102
SUCRALFATE 61 38 115 183
CARBAMAZEPINE 61 0 115 204
LOVASTATIN 60 37 118 44
TRAMADOL HCL-ACETAMINOPHEN 60 45 118 159
DILTIAZEM 24HR CD 59 48 120 132
OXYCONTIN 59 14 S2 120 144
TERAZOSIN HCL 58 53 122 136
IBUPROFEN 57 15 123 89
CARISOPRODOL 56 0 R 124 128
ALPRAZOLAM 54 44 125 124
OXYCODONE HCL-ACETAMINOPHEN 54 31 S2 125 83
GLIPIZIDE XL 52 31 127 220
BUPROPION XL 52 45 127 190
GLYBURIDE-METFORMIN HCL 52 40 R 127 140
RAMIPRIL 52 31 127 116
LEVEMIR 52 42 127 157
EVISTA 51 36 132 95
ABILIFY 51 12 132 150
COMBIVENT 51 20 132 131
MONTELUKAST SODIUM 50 14 135 195
FLUCONAZOLE 50 28 135 187
ZIPRASIDONE HCL 50 30 135 290
GEMFIBROZIL 50 34 135 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.